Live 3D contrast echocardiography can be a useful modality for definitively diagnosing and characterizing apical hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May aid select apical HCM cases; hypothesis-generating, requiring prospective validation before wider use.
We describe an adult patient in whom live three-dimensional transthoracic echocardiography combined with intravenous use of an echo contrast agent was useful in making a definitive diagnosis of apical hypertrophic cardiomyopathy and in characterizing the nature and full extent of the hypertrophy.
No takes yet. Share an insight, caveat, or question.
Frans et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: